As shown in Fig. 3B, when using 3 or 5 multi-gene combinations, the expression level of the MAPK9 gene was higher in HR + HER2 − cancer tissue than in para-carcinoma tissue (P < 0.05), while there was no significant difference between para-carcinoma tissue and benign tumor tissue. This evidence concerns the gene ERBB2 and cancer.